Ancillare
Ancillare is a privately held, founder-owned clinical trial ancillary supply chain management company that delivers end-to-end sourcing, kitting, cold chain, and global distribution of non-investigational supplies to pharmaceutical sponsors, CROs, SMOs, and biotech across 100+ countries.
- Company typePrivate
- Founded2006
- HeadquartersHorsham, United States
- Headcount251–500
- GTM typeB2B
- OfferingServices
What Ancillare does
Ancillare, LP is a privately held, founder-owned clinical trial ancillary supply chain management (CTASC™) company headquartered in Horsham, Pennsylvania, with European operations anchored in Amstelveen, Netherlands. Founded in 2006 by Dr. Joanne Santomauro, Ancillare created the CTASC category and provides end-to-end sourcing, kitting, labeling, cold chain management, global distribution, returns, reclamation, and disposition of non-investigational clinical trial supplies and equipment for Phase I–IV studies across more than 100 countries. The company has supported over 4,000 clinical trials reaching 200,000 clinical sites, operates 22 strategic depots across Europe, South America, and Asia-Pacific, and holds a stated 40.05% North American share of the clinical trial equipment and ancillary solutions market as of 2023.
Ancillare's core technology stack is built around four registered platforms. ANSUMS™ (2013) provides real-time inventory, resupply, and global reporting. ESTEEM™ (2014) aligns shipments with site-level patient enrollment for on-demand distribution. A-TKO™ (2015) is the flagship end-to-end managed service model bundling sourcing, distribution, project management, and ANSUMS dashboards. ADCP (April 2020) layers AI, analytics, and collaboration tools on top of 16 years of supply data to deliver predictive insights and sponsor-facing communications. Supporting services include cGMP-compliant clinical kitting (Horsham, PA facility renovated in 2023), Cold Chain Management (enhanced January 2025), medical consulting, and branded wearable distribution (Dexcom G7 CGM, February 2025). The Netherlands subsidiary NG BV, acquired in 2021, holds a Wholesale Distribution Authorization for medicinal products.
The revenue model is managed services with negotiated, quote-based program pricing per sponsor protocol. Customers are enterprise pharmaceutical sponsors, CROs, SMOs, and emerging biotech, served through direct field sales led by a dedicated business development function. Ancillare monetizes across the full trial lifecycle from startup to closeout and reports enabling 30%+ cost savings for sponsors. The company is WBENC-certified woman-owned, debt-financed via a multi-million dollar facility from Fulton Bank (2020), and continues to operate without disclosed institutional equity ownership. Customer counts, pricing tiers, and revenue figures are not publicly disclosed.
Ancillare firmographics
Firmographics- Name
- Ancillare
- Legal name
- Ancillare, LP
- Website
- https://ancillare.com
- Company type
- Private
- Founded year
- 2006
- Operating status
- Operating
- Headcount range
- 251–500 employees
- Short description
- Ancillare is a privately held, founder-owned clinical trial ancillary supply chain management company that delivers end-to-end sourcing, kitting, cold chain, and global distribution of non-investigational supplies to pharmaceutical sponsors, CROs, SMOs, and biotech across 100+ countries.
- Ownership category
- akta.pro rank
Ancillare industry classification
Industry- Product category
- Clinical Trial Ancillary Supply Chain Services
- NAICS
- Packaging and Labeling Services (56191)
- SIC
- Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047)
- akta.pro primary industry
- Clinical Trial Logistics & Depot Services (IRT-integrated, kitting, returns) (HLAGAMAC)
- akta.pro secondary industries
- Clinical Trials & Investigational Product (IP) Cold Delivery (TLAAAJAE), Pharmaceutical & Medical Device Packaging (GMP, Tamper-Evident, Cold-Chain Packs) (TLAIAGAI), Sample Logistics, Biorepository & IVD Kit Management (Trial Support) (HLAGAEAI)
Keywords
Where Ancillare is headquartered
LocationHeadquarters
- HQ city
- Horsham
- HQ country
- United States
- HQ region
- North America
Offices4 records
Markets served
Ancillare business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Supply Chain, Infrastructure, Marketing or Sales
Revenue model
- Clinical Trial Ancillary Supply Chain Management Services: Ancillare generates revenue through full-service management of clinical trial ancillary supplies and equipment for Phase I-IV studies. Services span sourcing, procurement, kitting, labeling, cold chain management, global distribution, returns, reclamation, and disposition. The company offers services at scale, enabling sponsors and CROs to realize 30%+ cost savings. Revenue is derived from service fees across the end-to-end trial lifecycle from startup to closeout.
Go-to-market motion1 record
Distribution channels4 records
Marketing channels8 records
Ancillare product offering
Product offeringCore offering
Ancillare is a full-service clinical trial ancillary supply chain management partner that sources, kits, labels, distributes, and reclaims non-investigational supplies and equipment for global Phase I-IV clinical trials. The company manages end-to-end operations across 22 strategic depots in 100+ countries, supported by proprietary technology platforms (ANSUMS, A-TKO, ADCP, ESTEEM) and in-house medical consulting. Services include cGMP-compliant clinical kitting, temperature-controlled cold chain logistics, and Direct-to-Patient distribution for pharmaceutical sponsors, biotechs, and CROs.
Product overview
Ancillare is a full-service clinical trial ancillary supply chain partner offering a unified platform-plus-services architecture. The core offering is anchored by A-TKO™ (Ancillare Turn-Key Operation), which serves as the overarching end-to-end management model supported by ANSUMS™ for real-time visibility and reporting, ESTEEM™ for enrollment-based distribution, and ADCP for AI-powered predictive insights and communications. These platforms integrate with specialized services including Clinical Kitting (cGMP-compliant), Cold Chain Management, and Medical Consulting. The company also distributes specific products like the Dexcom G7 CGM and manages equipment lifecycle from sourcing through reclamation across global Phase I-IV clinical trials spanning 100+ countries.
Differentiator
Problem solved
Functional benefit
Brands
- CTASC™ (Clinical Trial Ancillary Supply Chain): The Clinical Trial Ancillary Supply Chain management industry created by Ancillare in 2006, providing end-to-end solutions for non-investigational supplies and equipment in clinical trials.
- A-TKO™ (Ancillare Turn-Key Operations)
- ANSUMS™ (Ancillare Supply Chain Management System)
- ESTEEM™ (Executing Shipments Through Effective Enrollment Monitoring)
- ADCP (Ancillare Digital Communications Platform)
- Ancillare University
Products and services
- A-TKO (Ancillare Turn-Key Operation) Ancillare's flagship end-to-end clinical and ancillary supply chain management model for global clinical research sponsors. It combines sourcing and distribution, a dedicated program management team, real-time dashboard through ANSUMS, and full CTASC management from startup through closeout.
- Clinical Kitting Services Protocol-driven clinical kitting services performed in a cGMP-compliant Kitting Room, including ancillary trial kits, blood collection kits, nursing kits, patient supply kits, site support kits, and lab kits for specimen collection, with centralized inventory and GDP-compliant storage.
- Cold Chain Management Services Temperature-controlled cold chain services for clinical trial supplies, including temperature-controlled transportation, customs clearance, expiry monitoring, project management, and inventory management for temperature-sensitive clinical materials.
- Medical Consulting for Ancillary Supplies In-house medical consulting integrated into the CTASC model, providing therapeutic-area-informed supply recommendations, global product availability analysis, clinical justification for substitutions, and proactive risk identification for sponsors.
- Ancillary Supply Chain Management End-to-end management of non-investigational supplies required for clinical trials, including laboratory equipment, medical devices, diagnostics and testing kits, clinical site consumables, patient kits, monitoring devices, wearables, and general supplies, for Phase I-IV studies from startup to closeout.
- Dexcom G7 CGM Distribution Global distribution of the Dexcom G7 Continuous Glucose Monitor device for use in metabolic, endocrine, and decentralized clinical trials, providing real-time glucose monitoring for study participants.
Quantifiable outcome
- 30%+ cost savings for sponsors and CROs
- +2 more outcomes
Companies that use Ancillare
Customer profileNamed customers3 records
Segments4 records
Ideal customer profiles4 records
Ancillare technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability3 records
Feature4 records
Ancillare partnerships and signals
Strategic signalPartnerships
Nine partnerships are on record, tiered core and minor.
- Chad Finney (Senior Vice President of Business Development)coreChad Finney returned to Ancillare as Senior Vice President of Business Development in October 2025, bringing over 15 years of experience in clinical trial supply and healthcare. He previously served at Adwin Scientific, Slope, and Orifarm Clinical Trial Supplies, and is expected to define and execute Ancillare's global business development strategy.
- DexcomcoreAncillare became a global distributor of the Dexcom G7 Continuous Glucose Monitor (CGM) for clinical trials in February 2025. The Dexcom G7 provides real-time, precise glucose data for decentralized trials, improving participant compliance and reducing errors. Ancillare distributes this wearable device globally as part of its clinical trial supply services.
- Cold Chain Logistics PartnerscoreAncillare launched enhanced Cold Chain Management services in January 2025 for temperature-sensitive clinical trial supplies. The service covers sourcing, customs clearances, temperature-controlled transportation, monitoring product expiry, and inventory management — extending the company's existing cold chain capabilities globally.
- Temple University Fox School of BusinessminorCEO Dr. Joanne Santomauro was appointed to serve on the Supply Chain Management Advisory Board at Temple University's Fox School of Business in August 2024. The SCM Advisory Board, consisting of supply chain executives from various industries, shapes the next generation of supply chain professionals and bridges academia and industry.
- DTRA (Decentralized Trials & Research Alliance)minorAncillare joined the Decentralized Trials & Research Alliance (DTRA), an historic alliance of over one hundred life sciences and healthcare organizations that seeks to accelerate the broad adoption of patient-focused, decentralized clinical trials and research.
- NG BVcoreAncillare acquired NG BV, a Netherlands-based company authorized to procure, supply, and export medicinal products, holding a Wholesale Distribution Authorization (WDA). The acquisition deepens Ancillare's supply chain capabilities in the medicinal products space, allowing greater control and supply chain transparency for sponsors globally.
- Pennsylvania Biotechnology CenterminorAncillare is a member of the Pennsylvania Biotechnology Center, supporting the regional biotech innovation ecosystem in the Greater Philadelphia pharma corridor.
- GCSG (Global Clinical Supplies Group)minorAncillare is a member of the Global Clinical Supplies Group (GCSG), participating in annual conferences to explore trends in clinical supply chain management, discuss evolving regulatory challenges, and connect with sponsors, CROs, and supply partners.
- GCSG (Global Clinical Supplies Group)minorAncillare CEO Joanne Santomauro and VP of Quality Assurance Barbara Falco speak at GCSG conferences on topics like 'How Quality and Regulations Shape Clinical Trial Ancillary Supply.'
Scale indicators8 records
Recent moves14 records
Expansion highlights7 records
Ancillare competitors and assessment
Company assessmentBroad incumbents
- DHL Supply Chain Life Sciences: DHL Supply Chain's Life Sciences division provides global clinical trial logistics, cold chain, and storage services through its Life Sciences-grade facilities. As a broad incumbent, DHL competes with Ancillare on international clinical trial distribution, particularly in Europe and Asia.
- Catalent Clinical Supply Services (Novo Holdings): Catalent offers clinical supply services including packaging, kitting, storage, and global distribution alongside its broader CDMO business. Its clinical kitting and GMP-compliant operations directly overlap with Ancillare's cGMP kitting room offering.
- Fisher Clinical Services (Thermo Fisher Scientific): Fisher Clinical Services, part of Thermo Fisher, provides clinical trial packaging, labeling, distribution, and ancillary management at global scale. As a broad incumbent with much larger resources, it competes for multi-year sponsor contracts where Ancillare also operates.
- Clinigen Clinical Services: Clinigen provides clinical trial supply, comparator sourcing, and managed access programs through its Clinical Services division. Its comparator and ancillary supply capabilities overlap with Ancillare's product distribution and global trial support services.
Direct peers
- World Courier (Cencora/AmerisourceBergen): World Courier provides specialty logistics for clinical trials, including time- and temperature-sensitive transport of investigational products and ancillary supplies. Its global depot network and GxP-compliant services directly overlap with Ancillare's A-TKO model and cold chain offering.
- Marken (UPS Healthcare): Marken is a global clinical trial logistics provider offering time-sensitive and temperature-controlled distribution of clinical trial materials, including ancillaries and biospecimens. As a UPS subsidiary, it competes most directly with Ancillare's end-to-end ancillary supply chain and cold chain services for global Phase I-IV trials.
- Sharp Packaging (Sharp HealthCRE, UDG/Clinigen): Sharp provides clinical trial packaging, labeling, kitting, and global distribution services for pharma and biotech sponsors. Its core clinical supply offering competes with Ancillare's CTASC management and kitting services for Phase I-IV programs.
Emerging players
- Cryoport Systems: Cryoport provides temperature-controlled logistics for life sciences, including clinical trial materials requiring cryogenic shipping. Its focus on high-value biologics and cell/gene therapy trials overlaps with Ancillare's enhanced cold chain offering launched in January 2025.
- Bio-Storage Solutions (Circle Bio): Circle Bio (formerly Bio-Storage Solutions) provides biorepository, sample management, and clinical trial logistics services. Its biospecimen handling capabilities partially overlap with Ancillare's sample logistics and ancillary kit management functions.
Regional players
- Advent Clinical Trial Services: Advent provides clinical trial packaging, kitting, labeling, and distribution services primarily in North America. As a regional clinical supply services provider, it competes with Ancillare on kitting and ancillary supply for North American trials.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks6 records
Key highlights7 records
Customer concentration
Ancillare social profiles
Digital presenceAncillare compliance and trust
Trust signalCompliance5 records
Ancillare financial estimates
Financial estimateRevenue estimate
Valuation estimate
Ancillare leadership team
Management profileNumber of profiles
Profiles11 records
Ancillare subsidiaries and ownership
Company hierarchySubsidiaries2 records
Ancillare funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Ancillare M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Ancillare
What does Ancillare do?
Ancillare is a full-service clinical trial ancillary supply chain management partner that sources, kits, labels, distributes, and reclaims non-investigational supplies and equipment for global Phase I-IV clinical trials. The company manages end-to-end operations across 22 strategic depots in 100+ countries, supported by proprietary technology platforms (ANSUMS, A-TKO, ADCP, ESTEEM) and in-house medical consulting. Services include cGMP-compliant clinical kitting, temperature-controlled cold chain logistics, and Direct-to-Patient distribution for pharmaceutical sponsors, biotechs, and CROs.
Is Ancillare a public or private company?
Ancillare is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Ancillare founded?
Ancillare was founded in 2006. It employs 251 to 500 people.
Where is Ancillare based?
Ancillare is headquartered in Horsham, United States, in the North America region.
How does Ancillare make money?
One revenue line is on record: clinical Trial Ancillary Supply Chain Management Services.
Who are Ancillare's main competitors?
Broad incumbents on record are DHL Supply Chain Life Sciences, Catalent Clinical Supply Services (Novo Holdings), Fisher Clinical Services (Thermo Fisher Scientific) and Clinigen Clinical Services. Direct peers are World Courier (Cencora/AmerisourceBergen), Marken (UPS Healthcare) and Sharp Packaging (Sharp HealthCRE, UDG/Clinigen). Emerging players are Cryoport Systems and Bio-Storage Solutions (Circle Bio). Advent Clinical Trial Services is listed as a regional player.
Does Ancillare have an API?
No public API is recorded for Ancillare.
What industry is Ancillare in?
Ancillare's product category is Clinical Trial Ancillary Supply Chain Services. Its primary akta.pro industry code is HLAGAMAC, Clinical Trial Logistics & Depot Services (IRT-integrated, kitting, returns), with a secondary code of TLAAAJAE, Clinical Trials & Investigational Product (IP) Cold Delivery. Its NAICS code is 56191 and its SIC code is 5047.